Kochiashvili Giorgi, Fongrat Natalia, Baraskar Bhavana, Amare Biruk, Iantorno Micaela
Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
Oracle Heart & Vascular, Fredericksburg, VA 22401, USA.
J Clin Med. 2024 Aug 20;13(16):4907. doi: 10.3390/jcm13164907.
Calcified and resistant narrowing of arteries poses significant difficulty in performing percutaneous coronary interventions (PCIs), as they increase the risk of subpar outcomes leading to worse clinical outcomes. Despite the existence of dedicated technologies and devices, including various balloons and atherectomy systems, they often do not ensure sufficient plaque modification and ideal vessel preparation for optimal stent deployment. Intravascular lithotripsy (IVL), a technology originally developed for urological procedures, has recently been used to safely and selectively disrupt calcified depositions in both peripheral and coronary arteries by sonic waves that seamlessly transfer to nearby tissue, enhancing vessel compliance with minimal impact on soft tissues. In the coronary arteries, the use of IVL plays a role in the process of "vessel preparation" before the placement of stents, which is crucial for restoring blood flow in patients with severe coronary artery disease (CAD), and is considered a minimally invasive technique, reducing the need for open heart surgeries and associated risks and complications. Studies have shown that IVL can lead to improved procedural success rates and favorable long-term outcomes for patients with severely calcified coronary artery disease. With the advent of IVL, the disruption of severe calcification of coronary artery and stenotic lesions before stent implantations can be performed. Despite promising data for treating calcified lesions, IVL is significantly underutilized in clinical practice, long-term clinical data and extensive research are needed to validate its further safety and efficacy. In this article, we reviewed the literature discussing the use of IVL in the coronary arteries as an approach for addressing intravascular atherosclerotic plaques, particularly focusing on heavily calcified plaques that are resistant to standard initial PCI, while also evaluating its safety in comparison to alternative methods.
动脉的钙化和顽固性狭窄给经皮冠状动脉介入治疗(PCI)带来了巨大困难,因为它们会增加预后不佳的风险,导致更差的临床结果。尽管存在专门的技术和设备,包括各种球囊和旋切系统,但它们往往无法确保足够的斑块改良和理想的血管准备以实现最佳支架植入。血管内碎石术(IVL)最初是为泌尿外科手术开发的一种技术,最近已被用于通过无缝传递到附近组织的声波安全、选择性地破坏外周和冠状动脉中的钙化沉积物,在对软组织影响最小的情况下增强血管顺应性。在冠状动脉中,IVL在支架置入前的“血管准备”过程中发挥作用,这对于恢复严重冠状动脉疾病(CAD)患者的血流至关重要,并且被认为是一种微创技术,减少了心脏直视手术的需求以及相关风险和并发症。研究表明,IVL可以提高严重钙化冠状动脉疾病患者的手术成功率和长期预后。随着IVL的出现,可以在支架植入前对冠状动脉严重钙化和狭窄病变进行破坏。尽管治疗钙化病变的数据很有前景,但IVL在临床实践中的应用明显不足,需要长期临床数据和广泛研究来验证其进一步的安全性和有效性。在本文中,我们回顾了讨论IVL在冠状动脉中作为解决血管内动脉粥样硬化斑块方法的文献,特别关注对标准初始PCI耐药的重度钙化斑块,同时也与替代方法相比评估其安全性。